Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Si Shen, also known as Si Shen Wan, Si Shen Pills, or Si Shen Decoction, and available in granule form (四神颗粒剂), is a traditional Chinese medicine (TCM) formula. It is primarily used to treat gastrointestinal disorders such as diarrhea-predominant Irritable Bowel Syndrome (IBS-D), chronic colitis, ulcerative colitis, and daybreak diarrhea, by warming and tonifying the Spleen and Kidneys, astringing the intestines, and stopping diarrhea. It also demonstrates therapeutic potential in inflammatory conditions like Collagen-induced Arthritis (CIA) or Rheumatoid Arthritis (RA). Its mechanisms involve inhibiting apoptosis of intestinal epithelial cells, modulating inflammatory pathways (e.g., PI3K/Akt, p38 MAPK, FABP4/PPARγ/NFκB), regulating gut microbiota, and influencing various cytokine expressions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Si Shen.